/Companies

Neuro-Bio

Oxfordshire, GB · 1 known investors

Find your way into Neuro-Bio

Sign up to see every warm intro you have to Neuro-Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuro-Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Neuro-Bio is an Oxfordshire-based biotech company developing a biomarker and a diagnostic for Alzheimer's disease based on a novel hypothesis of the neurodegenerative process, originating from research at Oxford University. It also pursues neuroprotection approaches, with its first patent covering chemical composition of matter.

Founders & leadership

BS
Baroness Susan GreenfieldFounder

Investors · 1

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗
Registered name
NEURO-BIO LTD
Company number
08580518
Status
Active
Company type
Private limited company
Incorporated
21 Jun 2013
Registered office
Building F5, Culham Science Centre, Abingdon, Oxfordshire, OX14 3DB
Nature of business (SIC)
72190 — Other research and experimental development on natural sciences and engineering
Accounts
last made up to 31 Dec 2025 · next due 30 Sept 2027
Confirmation statement
last made up to 17 Jan 2026 · next due 31 Jan 2027

Current officers · 6

  • William Douglas Benjamin Anderson — director, appointed 24 Jan 2025
  • Susan Adele Greenfield — director, appointed 21 Jun 2013
  • Nora Stephanie Kawecki — director, appointed 1 Feb 2026
  • Gianluca Riccio — director, appointed 18 Feb 2026
  • Todd Stuart Thomson — director, appointed 5 Jun 2020
  • Da Secretarial Limited — corporate director, appointed 29 Aug 2023

Source: Companies House public register · retrieved 25 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Neuro-Bio do?
Neuro-Bio is an Oxfordshire-based biotech company developing a biomarker and a diagnostic for Alzheimer's disease based on a novel hypothesis of the neurodegenerative process, originating from research at Oxford University. It also pursues neuroprotection approaches, with its first patent covering chemical composition of matter.
Who are Neuro-Bio's investors?
Neuro-Bio's investors include Kairos Venture Investments, Llc.
Where is Neuro-Bio headquartered?
Neuro-Bio is headquartered in Oxfordshire, GB.